Barington Companies Management LLC Sells 50,000 Shares of Bath & Body Works, Inc. $BBWI

Barington Companies Management LLC cut its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 40.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 75,000 shares of the company’s stock after selling 50,000 shares during the quarter. Bath & Body Works accounts for 1.0% of Barington Companies Management LLC’s holdings, making the stock its 11th largest position. Barington Companies Management LLC’s holdings in Bath & Body Works were worth $1,506,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in BBWI. Global Retirement Partners LLC acquired a new stake in Bath & Body Works in the fourth quarter valued at approximately $31,000. Activest Wealth Management acquired a new stake in Bath & Body Works in the fourth quarter valued at approximately $32,000. Geneos Wealth Management Inc. boosted its position in Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after buying an additional 801 shares in the last quarter. Parallel Advisors LLC boosted its position in Bath & Body Works by 42.6% in the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock valued at $38,000 after buying an additional 567 shares in the last quarter. Finally, Danske Bank A S acquired a new stake in Bath & Body Works in the third quarter valued at approximately $39,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Price Performance

NYSE BBWI opened at $19.40 on Friday. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $33.96. The stock has a market capitalization of $3.91 billion, a PE ratio of 5.45, a P/E/G ratio of 1.87 and a beta of 1.42. The company’s 50 day simple moving average is $18.61 and its two-hundred day simple moving average is $20.07.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. The company had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.36 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The firm’s revenue was down 3.2% compared to the same quarter last year. During the same quarter last year, the company earned $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, research analysts anticipate that Bath & Body Works, Inc. will post 2.62 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, June 19th. Stockholders of record on Friday, June 5th will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, June 5th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.1%. Bath & Body Works’s payout ratio is presently 22.47%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. Barclays dropped their price target on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a research note on Thursday, May 28th. UBS Group dropped their price target on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, May 20th. Piper Sandler assumed coverage on shares of Bath & Body Works in a research note on Friday, May 15th. They set a “neutral” rating and a $20.00 price target for the company. Citigroup downgraded shares of Bath & Body Works from a “buy” rating to a “neutral” rating and raised their price target for the company from $21.00 to $25.00 in a research note on Tuesday, February 17th. Finally, Raymond James Financial reaffirmed a “market perform” rating on shares of Bath & Body Works in a research note on Wednesday, May 27th. Three research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $21.93.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.